Harvard Bioscience (HBIO) Profit After Tax Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn |
| 10 | Harvard Bioscience | 25.38 Mn | 18.29 Mn | 12.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -38.62% |
| Dec 31, 2025 | -35.86% |
| Sep 30, 2025 | -2.31% |
| Jun 30, 2025 | -7.62% |
| Mar 31, 2025 | -61.97% |
| Dec 31, 2024 | -49.54% |
| Sep 30, 2024 | -12.88% |
| Jun 30, 2024 | -63.96% |
| Mar 31, 2024 | -14.65% |
| Dec 31, 2023 | -20.59% |
| Sep 30, 2023 | -37.08% |
| Jun 30, 2023 | 7.71% |
| Mar 31, 2023 | 16.07% |
| Dec 31, 2022 | -172.93% |
| Sep 30, 2022 | -39.48% |
| Jun 30, 2022 | 42.84% |
| Mar 31, 2022 | -45.20% |
| Dec 31, 2021 | 22.23% |
| Sep 30, 2021 | 36.43% |
| Jun 30, 2021 | 10.48% |
| Mar 31, 2021 | -1.02% |
| Dec 31, 2020 | 48.60% |
| Sep 30, 2020 | -5.33% |
| Jun 30, 2020 | -45.54% |
| Mar 31, 2020 | -26.38% |
| Dec 31, 2019 | 98.67% |
| Sep 30, 2019 | -43.75% |
| Jun 30, 2019 | -17.52% |
| Mar 31, 2019 | -39.57% |
| Dec 31, 2018 | 44.83% |
| Sep 30, 2018 | -39.19% |
| Jun 30, 2018 | -51.08% |
| Mar 31, 2018 | -128.97% |
| Dec 31, 2017 | -14.98% |
| Sep 30, 2017 | -37.13% |
| Jun 30, 2017 | -19.12% |
| Mar 31, 2017 | -24.53% |
| Dec 31, 2016 | -30.53% |
| Sep 30, 2016 | -127.17% |
| Jun 30, 2016 | -20.31% |
| Mar 31, 2016 | -18.93% |
| Dec 31, 2015 | -58.02% |
| Sep 30, 2015 | -15.62% |
| Jun 30, 2015 | -28.61% |